NHS National Pharmaceuticals Dasatinib and Paliperidone Injection

A Contract Award Notice
by NHS ENGLAND

Source
Find a Tender
Type
Framework (Goods)
Duration
not specified
Value
£1
Sector
HEALTH
Published
27 Apr 2023
Delivery
not specified
Deadline
n/a

Concepts

Location

United Kingdom:

Geochart for 1 buyers and 6 suppliers

1 buyer

5 suppliers

Description

Proposed framework agreement for NHS National Generic Pharmaceuticals Dasatinib and Paliperidone Injection. Offer reference number: CM/PHG/22/5694Potential periods of call-offs under the framework agreement:CM/PHG/22/5694/00 - Dasatinib CESW 01/05/2023 – 30/04/2024 – (12 Months) LSNE 01/05/2023 – 30/04/2024 – (12 Months)NWLN 01/05/2023 – 30/04/2024 – (12 Months)CM/PHG/22/5694/01 - Paliperidone Injection: LSNE 01/05/2023 – 31/05/2024 (13 Months) NWLN 01/05/2023 – 31/01/2025 (21 months)

Lot Division

1 4. Lot 1 CM/PHG/22/5694/00 Supplier offer confirmation (check box)

Invitation to offer for NHS National Generic Pharmaceuticals - Dasatinib and Paliperidone InjectionPeriod of framework agreement: The total maximum duration of the framework agreement to be no more than 21 months with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 48 months. Potential periods of call-offs under the framework agreement:CM/PHG/22/5694/00 - Dasatinib CESW - 01/05/2023 … – (12 Months) LSNE - 01/05/2023 … – (12 Months)NWLN - 01/05/2023 … - Paliperidone Injection: LSNE - 01/05/2023 – 31/05/2024 (13 Months) NWLN - 01/05/2023
2 5. Lot 2 CM/PHG/22/5694/01 Supplier offer confirmation (check box)

Invitation to offer for NHS National Generic Pharmaceuticals - Dasatinib and Paliperidone InjectionPeriod of framework agreement: The total maximum duration of the framework agreement to be no more than 21 months with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 48 months.Potential periods of call-offs under the framework agreement:CM/PHG/22/5694/00 - DasatinibCESW - 01/05/2023 … – (12 Months)LSNE - 01/05/2023 … – (12 Months)NWLN - 01/05/2023 … - Paliperidone Injection:LSNE - 01/05/2023 – 31/05/2024 (13 Months)NWLN - 01/05/2023

Award Detail

1 Zentiva Pharma (Felstead)
  • Lot 1-CM/PHG/22/5694/00
  • Reference: 012161-2023-1
  • Value: £1
2 Teva (Castleford)
  • Lot 1-CM/PHG/22/5694/00
  • Reference: 012161-2023-2
  • Value: £1
3 Mylan (Hatfield)
  • Lot 1-CM/PHG/22/5694/00
  • Reference: 012161-2023-3
  • Value: £1
4 Janssen Cilag (High Wycombe)
  • CM/PHG/22/5695/01
  • Reference: 012161-2023-4
  • Value: £1
5 Teva (Castleford)
  • CM/PHG/22/5695/01
  • Reference: 012161-2023-5
  • Value: £1
6 Mercury Pharmaceuticals (London)
  • CM/PHG/22/5695/01
  • Reference: 012161-2023-6
  • Value: £1

Award Criteria

price _

CPV Codes

  • 33600000 - Pharmaceutical products

Indicators

  • Options are available.

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. **

Reference

Domains